...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Vacepa new

Vascepa showed 26% lowering of 3-point and 25% lowering in 5-point MACE in the REDUCE-IT trial. 

Share
New Message
Please login to post a reply